The Lost Soviet Probiotic: How a Bulgarian Cancer Discovery Became a Cold War Secret

Summary

Between 1905 and the collapse of the Soviet Union, a remarkable thread of scientific research connected Bulgarian yogurt culture, cancer immunotherapy, bioweapons defense, and radiation protection — all centered on a single bacterium: Lactobacillus delbrueckii subsp. bulgaricus. This research, conducted across Bulgaria, Russia, and Ukraine, produced genuine breakthroughs that were classified under Soviet state secrecy. When the USSR dissolved, the scientists who had spent decades developing these products found themselves in a fragmented post-Soviet landscape with no state funding. The technology eventually reached the West not as a pharmaceutical — but as a dietary supplement called Del-Immune V.

The story is a case study in how states suppress knowledge — not always through malice, but through the bureaucratic machinery of secrecy, ideological rigidity, and institutional inertia.

Part I: The Bulgarian Foundations (1905–1960)

Stamen Grigorov and the Discovery of L. bulgaricus

In 1905, a 27-year-old Bulgarian physician named Stamen Grigorov (1878–1945), working in Professor Léon Massol’s microbiology laboratory at the University of Geneva, isolated a rod-shaped bacterium from a sample of Bulgarian yogurt (kiselo mlyako). He published his findings as “Étude sur une lait fermentée comestible: Le ‘Kissélo mléko’ de Bulgarie” in the Revue Médicale de la Suisse Romande (1905). The bacterium was named Bacillus bulgaricus in his honor — later reclassified as Lactobacillus delbrueckii subsp. bulgaricus.

Sources:

• Grigoroff, Stamen (1905). Étude sur une lait fermentée comestible. Revue Médicale de la Suisse Romande. Genève.
• Wikipedia: Stamen Grigorov

Grigorov did not stop at yogurt. In 1906, collaborating with Albert Calmette (co-developer of the BCG tuberculosis vaccine), he demonstrated that Penicillium mold — decades before Fleming’s famous discovery — could treat tuberculosis in laboratory and human subjects. This contribution was largely forgotten.

Ilya Metchnikoff and the Longevity Hypothesis

The Bulgarian discovery attracted the attention of Ilya Ilyich Metchnikoff (1845–1916), the Russian-born Nobel laureate (1908) at the Pasteur Institute in Paris. Metchnikoff proposed that the exceptional longevity of Bulgarian and Southeastern European rural populations was linked to their daily consumption of fermented milk containing L. bulgaricus. His theory: lactic acid bacteria suppress the putrefactive intestinal microbes that accelerate aging through “autointoxication.”

Though his specific claims about L. bulgaricus surviving in the human gut were challenged by Cheplin & Rettger (1920), Metchnikoff’s work launched the entire field of probiotics. He was, in effect, the founding father of microbiome science — a century before the term existed.

Sources:

• Anukam, Kingsley C. et al. “Probiotics: 100 years (1907–2007) after Elie Metchnikoff’s Observation.” (PDF, archived)
• Cheplin, H. A.; Rettger, L. F. (1920). “Studies on the Transformation of the Intestinal Flora.” PNAS 6(12): 704–705.

Ivan Bogdanov and the Anti-Tumor Discovery (1960s)

In the early 1960s, Dr. Ivan Bogdanov, a Bulgarian physician and microbiologist, took this research in a radical new direction. Working with various Lactobacillus strains, Bogdanov discovered that structural fragments (not live cells) of L. bulgaricus strain #51 could influence tumor cell growth.

According to a monograph by Helen Nauts of the Cancer Research Institute (New York), Bogdanov prepared a cell-fragment mixture from L. bulgaricus and administered it to two patients with multiple myeloma. Both patients achieved remission — one surviving 18 months before dying of influenza, the other surviving 45 months. The median survival for myeloma at that time was approximately 12–18 months.

Sources:

• Nauts, Helen C. (1975). “Multiple Myeloma: Beneficial Effects of Acute Infections Or Immunotherapy (Bacterial Vaccines).” Cancer Research Institute Monograph #13. (Archived PDF)
• Wikipedia: Lactobacillus delbrueckii subsp. bulgaricus — Immunotherapy for cancer
• Minnesota Wellness Directory: Del-Immune V

Wikipedia notes: “references are internal documents and conversations among hospitals; there’s no mention in English medical literature.” A documentary and article exist in Bulgarian. This is the characteristic footprint of research that occurred behind the Iron Curtain — documented internally, classified externally, and invisible to Western databases.

Part II: The Soviet State Program (1979–1991)

Enzymes Ltd. and the Classified Research

Bogdanov’s discovery attracted the attention of Soviet research institutes. In 1980, the USSR created a State R&D program to research bacterial cell fragments for use in medicine. The primary organization chosen was Enzymes Ltd., a biopharmaceutical company based in Kiev, Ukrainian SSR.

Dr. Liubov Shynkarenko (now Dr. Liubov Sichel) joined Enzymes Ltd. in 1979 and became the coordinator/leader of the team from the Enzymes group, eventually rising to Head of Central R&D Laboratories and Vice Director General. In a 2024 interview with Stellar Biotics, she provides the most authoritative first-person account of this research:

The researchers tested multiple types of bacterial microorganisms. Lactobacillus proved safest and most effective — other bacterial cultures showed higher biological activity but unacceptable toxicity.

Source:

• Stellar Biotics (2024). “Dr. Liubov Sichel, Co-founder of del-IMMUNE V®, Shares the Product’s Fascinating History”

What Were They Protecting Against?

The context matters enormously. This research coincided with the peak of the Soviet biological weapons program — the largest in history. Under the civilian cover organization Biopreparat, established in 1973, the USSR maintained 40–50 military-purposed biological research facilities employing tens of thousands of personnel. Their work included weaponizing anthrax, plague, tularemia, botulinum toxin, and smallpox.

The “defensive” side of this program — protecting Soviet citizens and soldiers against both enemy bioweapons and the USSR’s own biological agents — created a natural demand for broad-spectrum immune boosters. A substance derived from Lactobacillus cell fragments that could enhance immune function, protect against radiation, and guard genetic material from mutagenic damage would be extraordinarily valuable to a state simultaneously developing bioweapons and operating nuclear facilities.

This dual-use context explains completely why the research was classified. It was not merely probiotic science — it was part of the Soviet defense establishment’s response to its own biological and nuclear programs.

Sources:

• Wikipedia: Soviet biological weapons program
• National Security Archive, George Washington University: “Cracking open the Soviet biological weapons system, 1990”
• Carmen Chas (2022). “Biopreparat: The Soviet biological weapons programme.” Research at Kent Working Paper. (PDF)

The Three Products

By the late 1980s, after pre-clinical testing, the Enzymes Ltd. team had focused on L. delbrueckii strains 86 and LE and developed three final medical products:

1. Lactoflor — a probiotic product containing live Lactobacillus cells
2. Extrabiol — a probiotic lysate (fluid containing broken cell contents: cell wall fragments, DNA fragments) — the direct predecessor of Del-Immune V
3. Blasten (Liasten) — pure cell wall derivatives: muramyl penta-peptides + DNA fragments — the most concentrated form

Dr. Sichel is explicit that the Chernobyl claims are overstated:

Human testing only became possible in the 1990s, during the collapse of the Soviet Union.

Part III: The Post-Soviet Diaspora (1991–present)

The Dissolution of the State Program

When the USSR collapsed in 1991, the State R&D program was dissolved. Overnight, the funding structure, institutional framework, and security apparatus that had supported this research for over a decade ceased to exist. The technological and biomedical research continued in Ukraine — but under radically different conditions.

Liasten: The Cancer Drug That Almost Was

The most potent product from the research — Liasten (also written Blasten), made from pure cell-wall derivatives — did achieve formal recognition. It was approved by the Ukrainian Ministry of Health as a breast cancer treatment agent. As of 2024, it continues to be researched for treating various tumor types, infectious diseases, chronic cardiovascular diseases, metabolic disorders, and other immune-system-related conditions.

This is a striking detail: a product derived from the same research lineage that began with Bogdanov’s 1960s myeloma experiments has achieved formal government approval for cancer treatment — yet it remains virtually unknown outside Ukraine. No English-language medical literature discusses it. No Western pharmaceutical company has licensed it. It exists in a regulatory no-man’s-land between the collapsed Soviet state program and the Western pharmaceutical pipeline.

Del-Immune V: The Supplement Path

Dr. Shynkarenko (Sichel) eventually emigrated and co-founded Stellar Biotics LLC (Rockleigh, New Jersey). In 1999, her team at a Ukrainian Biotechnology faculty lab isolated a new strain — Lactobacillus rhamnosus DV — from fermented medicinal herbs. After testing, this strain’s lysate showed “widespread and potent immune system regulation” similar to Extrabiol.

This became Del-Immune V — marketed as a dietary supplement containing cell wall fragments from L. rhamnosus DV. It is the direct commercial descendant of the classified Soviet research. Because it is sold as a supplement rather than a drug, it avoids the multibillion-dollar FDA approval process — but also lacks the clinical trial infrastructure that would establish it in mainstream medicine.

A Phase 1 clinical trial for Stage III colorectal cancer has been conducted using Del-Immune V, according to documents available on Stellar Biotics’ website.

Sources:

• Stellar Biotics: Learn About del-IMMUNE V®
• Stellar Biotics (2024). Phase 1 Clinical Trial PDF

Part IV: Modern Corroboration — Probiotics and Radiation Protection

The Soviet research on probiotic radioprotection, once classified and dismissed, is now being confirmed by independent Western research:

• Ciorba et al. (2012). “Lactobacillus probiotic protects intestinal epithelium from radiation injury.” Gut 61(6): 829. PubMed: 22027478. — Demonstrated that Lactobacillus rhamnosus GG protects against radiation injury via Toll-like receptor-2 signaling and release of lipoteichoic acid.

• Bacterial supplementation in mitigation of radiation-induced gastrointestinal damage (2024). Life Sciences – ScienceDirect. — Reviews mechanisms by which bacterial cell fragments (not live cells) protect intestinal stem cells from radiation through prostaglandin E2 (PGE2) signaling.

• MDPI (2024). “Microbiota-Induced Radioprotection: A Novel Approach to Enhance Treatment Outcomes.” — Proposes integrating synthetic biology with probiotic therapy for radiation-induced gastrointestinal toxicity.

• Protein & Cell (2024). “Radiation injury and gut microbiota-based treatment.” — Comprehensive review of microbiome-based approaches to radiation damage.

The mechanism the Soviet researchers described — probiotic cell fragments protecting genetic material from radiation and mutagenic damage — aligns with what Western science is now rediscovering through different experimental frameworks.

Part V: The Garbled Telephone — How This Story Reached America

The real story was distorted through retelling. In the version popularized by American speakers like David Lester Straight (1963–2025), a sovereign-citizen movement figure who claimed CIA connections, the narrative became:

• “Dr. Lawrence Royce” (non-existent) instead of Dr. Ivan Bogdanov / Dr. Liubov Shynkarenko
• A “Chernobyl blue area” (undocumented) instead of in-vitro and animal testing during the 1980s
• A miracle cure suppressed to protect pharmaceutical profits, instead of classified Cold War defense research
• “Lactobacillus salivarius” instead of L. delbrueckii / L. rhamnosus
• Fluoride conspiracy (irrelevant) mixed in with genuine probiotic science

The irony: the real story is more remarkable than the garbled version. A Bulgarian physician discovers that fragments of a yogurt bacterium can put cancer into remission. The Soviet state classifies this under bioweapons defense. The research proves that these same fragments protect against radiation — just as the Chernobyl disaster strikes. The state collapses, the funding evaporates, the scientist emigrates to New Jersey and sells it as a supplement. Meanwhile, a cancer drug derived from the same research is approved in Ukraine and unknown everywhere else.

No conspiracy is needed. The machinery of secrecy, institutional collapse, and regulatory barriers did the work without anyone needing to orchestrate it.

Timeline

Assessment

What is real:

• Bulgarian and Soviet scientists discovered that Lactobacillus cell fragments have genuine immunomodulatory, anti-tumor, and radioprotective properties
• The research was classified under the Soviet bioweapons/defense establishment
• The Chernobyl disaster did NOT directly trigger this research (it predated Chernobyl by decades) but the disaster demonstrated the urgent need for radioprotective agents
• Modern Western research independently confirms probiotic radioprotection via multiple mechanisms
• A cancer drug (Liasten) derived from this research was approved in Ukraine
• The commercial product Del-Immune V is the direct descendant of classified Soviet science

What is unresolved:

• The full extent of Bogdanov’s work remains in Bulgarian-language sources and internal hospital documents
• Whether large-scale human trials were ever conducted under Soviet secrecy
• The complete list of applications tested by Enzymes Ltd.
• Why no Western pharmaceutical company has pursued this research through FDA clinical trials

What the suppression tells us: The Soviet state classified this research not because it didn’t work, but because it did — and it had defense applications. When the state collapsed, there was no institutional successor to declassify, fund, and advance the research. The Western pharmaceutical system, designed around patentable synthetic molecules, had no economic incentive to invest in unpatentable bacterial cell fragments. The result: a potentially transformative medical discovery fell into a bureaucratic gap between two systems — neither of which was designed to nurture it.

Document created: 2026 Related: Transcript of David Straight talk | Investigation of transcript claims

Keywords: #Soviet #Probiotic #Research #Real #Story #Lost #Bulgarian #Cancer #Discovery #Became #Cold #War #Secret